. Renal segmental microvascular responses to ANG II in AT1A receptor null mice. Am J Physiol Renal Physiol 284: F538-F545, 2003. First published November 12, 2002 10.1152/ajprenal.00340. 2002The relative contributions of AT 1A and AT1B receptors to afferent arteriolar autoregulatory capability and afferent and efferent arteriolar responses to ANG II are not known. Experiments were conducted in kidneys from wildtype (WT) and AT 1AϪ/Ϫ mice utilizing the in vitro bloodperfused juxtamedullary nephron technique. Direct measurements of afferent (AAD) and efferent arteriolar diameters (EAD) were assessed at a renal arterial pressure of 100 mmHg. AAD averaged 14.8 Ϯ 0.8 m for WT and 14.9 Ϯ 0.8 m for AT1AϪ/Ϫ mice. AAD significantly decreased by 7 Ϯ 1, 16 Ϯ 1, and 26 Ϯ 2% for WT mice and by 11 Ϯ 1, 20 Ϯ 2, and 30 Ϯ 3% for AT1AϪ/Ϫ mice (120, 140, 160 mmHg). AAD autoregulatory capability was not affected by the absence of AT1A receptors. AAD responses to 10 nM ANG II were significantly blunted for AT1AϪ/Ϫ mice compared with WT (Ϫ22 Ϯ 2 vs. Ϫ37 Ϯ 5%). ANG II (0.1-10 nM) failed to elicit any change in EAD for AT1AϪ/Ϫ mice. AAD and EAD reductions in ANG II were blocked by 1 M candesartan. We conclude that afferent arteriole vasoconstrictor responses to ANG II are mediated by AT1A and AT1B receptors, whereas efferent arteriolar vasoconstrictor responses to ANG II are mediated by only AT1A receptors in the mouse kidney. afferent arteriole; efferent arteriole; juxtamedullary nephron; candesartan; autoregulation THERE ARE AT LEAST TWO MAJOR angiotensin receptors: AT 1 and AT 2 . The AT 1 receptor is thought to mediate most of the actions of ANG II on renal hemodynamic and tubular function, including afferent and efferent arteriolar vasoconstriction (3, 9, 31), modulation of tubuloglomerular feedback sensitivity (16), sodium and fluid reabsorption (18), and growth and differentiation (29). Two subtypes of the AT 1 receptors, designated AT 1A and AT 1B , have been identified in the rat (7, 12, 13, 23) and mouse (24). The AT 1A receptor is thought to be the predominant renal form. Terada et al. (28) reported localization of the AT 1 receptor mRNA in microdissected renal vascular segments (glomeruli, vasa recta bundle, and arcuate arteries) of the kidney by RT-PCR methods. Further studies identified AT 1A and AT 1B mRNAs in the same renal vascular structures, as well as the afferent arteriole (2, 7). Additionally, the AT 1 receptor protein has been localized to the entire rat renal vasculature using immunohistochemical techniques and antibodies that recognize specifically the AT 1A receptor (30) or both the AT 1A and AT 1B receptor subtypes (10, 17, 21, 30) . The mRNA and protein expression profiles of the AT 1 receptor subtypes have not been determined for the efferent arteriole. Furthermore, the contribution of the AT 1A and AT 1B receptors to the afferent and efferent arteriolar responses to ANG II have not been investigated.
THERE ARE AT LEAST TWO MAJOR angiotensin receptors: AT 1 and AT 2 . The AT 1 receptor is thought to mediate most of the actions of ANG II on renal hemodynamic and tubular function, including afferent and efferent arteriolar vasoconstriction (3, 9, 31) , modulation of tubuloglomerular feedback sensitivity (16) , sodium and fluid reabsorption (18) , and growth and differentiation (29) . Two subtypes of the AT 1 receptors, designated AT 1A and AT 1B , have been identified in the rat (7, 12, 13, 23) and mouse (24) . The AT 1A receptor is thought to be the predominant renal form. Terada et al. (28) reported localization of the AT 1 receptor mRNA in microdissected renal vascular segments (glomeruli, vasa recta bundle, and arcuate arteries) of the kidney by RT-PCR methods. Further studies identified AT 1A and AT 1B mRNAs in the same renal vascular structures, as well as the afferent arteriole (2, 7) . Additionally, the AT 1 receptor protein has been localized to the entire rat renal vasculature using immunohistochemical techniques and antibodies that recognize specifically the AT 1A receptor (30) or both the AT 1A and AT 1B receptor subtypes (10, 17, 21, 30) . The mRNA and protein expression profiles of the AT 1 receptor subtypes have not been determined for the efferent arteriole. Furthermore, the contribution of the AT 1A and AT 1B receptors to the afferent and efferent arteriolar responses to ANG II have not been investigated.
The AT 1A and AT 1B receptors are pharmacologically indistinguishable from each other, and so it has not been possible to discriminate between the receptor subtype functions using pharmacological antagonists. The physiological effects of renal AT 1A and AT 1B receptor subtypes have yet to be elucidated, although the calcium signaling mechanisms of the AT 1A and AT 1B receptors appear to be identical in isolated cells (15, 32) . The AT 1A and AT 1B receptor subtype localization, regulation, and function in various pre-and postglomerular microvascular segments may play an important part in the renal hemodynamic responses to ANG II in a variety of physiological and pathophysiological conditions.
Gene-targeted mice have proven to be a critical tool in defining the role of each AT 1A and AT 1B receptor subtype in vivo. AT 1A Ϫ/Ϫ mice have reduced blood pressure, lack a systemic pressor response to exogenous ANG II, and exhibit mild renal structural abnormalities that include slight papillary hypoplasia and hyperplasia of renin-producing granular cells (11, 20, 26) . Surprisingly, renal hemodynamics of wild-type (WT) and AT 1A Ϫ/Ϫ mice are similar, such that glomerular filtration rate and renal plasma flow (6) and renal blood flow (22) do not differ between anesthetized WT and AT 1A Ϫ/Ϫ mice; however, renal vascular resistance is lower in the AT 1A Ϫ/Ϫ mice, paralleling the lower arterial pressure (22) . The reduction in renal blood flow produced by ANG II in WT mice is similar to the reduction in renal blood flow produced by 10-fold higher doses of ANG II in AT 1A Ϫ/Ϫ mice (22) . However, the renal microvascular segment responsible for the ANG II responsiveness in AT 1A Ϫ/Ϫ mice could not be determined in these studies. Additionally, AT 1A Ϫ/Ϫ mice lack a tubuloglomerular feedback mechanism (25) , which may result in an impaired renal autoregulatory responsiveness in these mice.
The present studies were conducted to test the hypotheses that AT 1A Ϫ/Ϫ receptor-deficient mice display impaired renal afferent arteriolar autoregulatory responses and altered afferent and efferent arteriolar ANG II sensitivity. To directly assess the renal microvascular responses to changes in renal arterial perfusion pressure and ANG II, vessels were studied in an intact tubular environment (5) using the mouse in vitro blood-perfused juxtamedullary nephron preparation.
METHODS

Mouse in vitro blood-perfused juxtamedullary nephron
technique. Assessment of afferent and efferent arteriolar diameters was conducted in kidneys from 49 adult male and female WT (n ϭ 14 females; n ϭ 4 males), AT 1Aϩ/Ϫ (n ϭ 4 males), and AT1AϪ/Ϫ (n ϭ 22 females; n ϭ 5 males) mice ranging from 3 to 7 mo of age that were breed in our colony at Duke University. Forty-nine adult male Sprague-Dawley rats were used as blood donors. Experiments were conducted using the mouse in vitro blood-perfused juxtamedullary nephron technique, which is based on the rat in vitro bloodperfused juxtamedullary nephron technique originally developed by Casellas et al. (4) . Kidneys were harvested from mice under pentobarbital sodium anesthesia (50 mg/kg ip). The renal artery was cannulated via the descending aorta under a dissecting microscope and immediately perfused with a Tyrode buffer containing 51 g/l bovine serum albumin (98-99% albumin, Sigma) and a mixture of L-amino acids at pH 7.4 as previously described in detail (8) . The cannula system includes a 27-gauge blunted hypodermic needle for introduction into the renal artery, polyethylene (PE)-10 tubing for blood perfusion, and PE-10 tubing for the measurement of perfusion pressure. The tips of all of the tubing are in close proximity to each other. A section of liver was removed from each animal, immersed into liquid nitrogen, and stored at Ϫ70°C for genotyping by Southern blot analysis as previously described (11) . The kidney was placed in a perfusion chamber at room temperature for the dissection procedure, which included removal of the ventral third of the kidney, reflection of the papilla, cutting open of the renal veins, placement of 10.0 suture ties on the distal segments of the large arteries, and removal of the connective tissue and pelvic mucosa overlying the juxtamedullary cortical surface (Fig. 1A) .
Blood was collected from a pentobarbital sodium anesthetized rat (50 mg/kg ip) through a carotid arterial cannula into a heparinized syringe. Blood was centrifuged, the buffy coat was discarded, and plasma and red blood cells (RBCs) were separated. RBCs were washed 2ϫ in 0.9% NaCl, and the plasma was filtered (0.2, 5 m). After completion of all microdissection procedures, the Tyrode perfusate was replaced with the reconstituted rat blood (hematocrit 33%). Microscopic examination of RBCs from the rat and mouse indicate that the diameters are similar (4-6 m mouse; 5-7 m rat). There was no indication that perfusion of the mouse kidney with rat blood causes any limitations in glomerular capillary blood flow or alterations in vascular responses. Renal arterial perfusion pressure was measured using a P23XL transducer and a polygraph and was maintained at 100 mmHg by adjusting the regulator controlling the flow of the O 2-CO2 mixture from the tank that pressurized the reservoir. The perfusion chamber was warmed, and the tissue surface was continuously superfused with an albumincontaining (10 g/l) Tyrode solution at 37°C. Agents were administered by addition to this bathing solution. The chamber was affixed to the stage of a Nikon Optiphot microscope equipped with dry objectives (ϫ4, ϫ10, ϫ32) and a waterimmersion objective (Zeiss, ϫ40/0.75 numerical aperture) (Fig. 1B) . The tissue was transilluminated using a halogen lamp. The focused image of the vessel was transmitted via a high-resolution Newvicon camera (NC-67M, Dage-MTI) through a time-date generator (WJ-810, Panasonic) and an image-enhancing processor (MFJ-1452, MFJ Enterprises) and displayed on a monochromatic monitor (final magnification ϫ3,500). The video signal was recorded simultaneously on videotape for later analysis (SuperVHS VCR, Panasonic). Diameter measurements were obtained at a single site along the length of the selected vessel using an image-shearing monitor (Instrumentation for Physiology and Medicine, San Diego, CA). This device was calibrated using a stage micrometer (smallest division ϭ 10 m) and yielded diameter measurements reproducible to within Ͻ0.1 m. Afferent arterioles were studied near the glomerulus in the region sensitive to input from tubuloglomerular feedback. Efferent arterioles were studied near the glomerulus before peritubular capillary branching. Afferent arterioles (Fig. 1C) were measured at a site averaging 60 Ϯ 2 m from the glomerulus (n ϭ 35). Afferent arteriolar total length averaged 280 Ϯ 20 m (n ϭ 35). Efferent arterioles were measured at a site averaging 60 Ϯ 3 m from the glomerulus (n ϭ 14). Experimental protocols were begun after a 10-to 15-min stabilization period. A single vessel was studied from each kidney, and only one kidney was studied from each animal.
Afferent arteriolar autoregulatory responses. Afferent arteriolar diameters were monitored in response to elevations in renal perfusion pressure in kidneys from female WT (n ϭ 6), AT 1Aϩ/Ϫ (n ϭ 2), and AT1AϪ/Ϫ (n ϭ 6) mice. Afferent arteriolar diameters were measured during a 5-min control period at 100 mmHg. Renal perfusion pressure was increased in a stepwise fashion to 120, 140, and 160 mmHg as previously described for studies in the rat kidney (27) . The pressures were maintained at each level for 3 min. Pressure was then returned to 100 mmHg for a 5-min recovery period. In a subset of mice, ANG II dose responses were determined after the recovery period, as described below.
Afferent arteriolar ANG II responses. Afferent arteriolar diameters in kidneys from male and female WT (n ϭ 9 females; n ϭ 2 males), AT1Aϩ/Ϫ (n ϭ 4 females) and AT1AϪ/Ϫ (n ϭ 14 females; n ϭ 3 males) mice were measured during superfusion with ANG II. After a 5-min control period or recovery from the change in perfusion pressure protocol, the kidneys were superfused sequentially with 0.1, 1.0, and 10 nM ANG II for a period of 5 min for each concentration. A recovery period of 5 min was then observed. Kidneys were then superfused for 5 min with an AT1 receptor blocker (1 M candesartan), and the ANG II concentration-response relationship was repeated in the same vessel from WT (n ϭ 5), AT1Aϩ/Ϫ (n ϭ 2), and AT1AϪ/Ϫ (n ϭ 11) mice.
Afferent arteriolar ANG II time control responses. Afferent arteriolar diameters were measured in kidneys from female AT1AϪ/Ϫ mice (n ϭ 3) in response to 0, 0.1, 1.0, 10, and 0 nM ANG II for a period of 5 min for each concentration. This protocol was repeated in the same vessels to demonstrate that the vasculature responds to a second application of ANG II.
Efferent arteriolar ANG II responses. Efferent arteriolar diameters in kidneys from male and female WT (n ϭ 5 females; n ϭ 2 males) and AT 1AϪ/Ϫ (n ϭ 5 females; n ϭ 2 males) mice were measured during superfusion with ANG II. After a 5-min control period, the kidneys were superfused with 0.1, 1.0, and 10 nM ANG II for a period of 5 min for each concentration. A recovery period of 5 min was then observed. Kidneys were then superfused for 5 min with an AT 1 receptor blocker (1 M candesartan). The ANG II dose-response relationship was repeated in the same vessel in all kidneys.
Data analysis. Afferent and efferent arteriolar luminal diameters were measured at 12-s intervals throughout the entire protocol. Plateau responses were determined by averaging data obtained during the final 2 min of each treatment period and used for statistical analysis. Statistical analyses were performed using SigmaStat statistical software on the raw data by one-way or two-way analysis of variance, followed by Tukey's test or paired t-test as appropriate. Baseline diameters were analyzed by unpaired t-test. A P value Ͻ0.05 was considered statistically significant. All data are presented as the means Ϯ SE (n ϭ no. of arterioles).
RESULTS
Animals.
Body weights of the three genotypes of mice averaged 39 Ϯ 2 g for WT (n ϭ 18), 37 Ϯ 5 g for AT 1A ϩ/Ϫ (n ϭ 4), and 33 Ϯ 1 g for AT 1A Ϫ/Ϫ (n ϭ 27) mice. Body weights of AT 1A Ϫ/Ϫ mice were significantly smaller than those of WT mice (P Ͻ 0.05).
Afferent arteriolar autoregulatory responses. Afferent arteriolar baseline diameters were not significantly different between WT (n ϭ 6) and AT 1A Ϫ/Ϫ (n ϭ 6) mice, averaging 14.8 Ϯ 0.8 and 14.9 Ϯ 0.8 m, respectively. After stepwise increases in renal perfusion pressure to 120, 140, and 160 mmHg, afferent arteriolar diameters significantly decreased by 7 Ϯ 1, 16 Ϯ 1, and 26 Ϯ 2% for WT mice and by 11 Ϯ 2, 23 Ϯ 5, and 30 Ϯ 5% for AT 1A Ϫ/Ϫ mice, respectively (Fig. 2) . Afferent arteriole diameters were significantly reduced at each step increase in perfusion pressure in kidneys of WT and AT 1A Ϫ/Ϫ mice. Afferent arteriolar diameters were not significantly different during the recovery period compared with baseline diameters in each group. Afferent arterioles from AT 1A ϩ/Ϫ (n ϭ 2) mice displayed a similar pattern of response. Afferent arteriolar diameters for AT 1A ϩ/Ϫ mice decreased 11, 25, and 31% of the baseline of 15.1 m when renal perfusion pressure was increased from 100 to 120 to 140 to 160 mmHg, respectively. WT, AT 1A ϩ/Ϫ, and AT 1A Ϫ/Ϫ mice exhibited similar afferent arteriolar autoregulatory responses to increases in renal perfusion pressure. The magnitude of the responses was not different between WT and AT 1A Ϫ/Ϫ mice (P ϭ 0.6), demonstrating active afferent arteriolar responses to increases in renal perfusion pressure in the absence of the AT 1A receptor.
Afferent arteriolar ANG II responses. Baseline afferent arteriolar diameters were similar in kidneys from WT (n ϭ 11) and AT 1A Ϫ/Ϫ (n ϭ 17) mice subjected to ANG II challenges, averaging 14.6 Ϯ 0.4 and 15.2 Ϯ 0.4 m, respectively. Afferent arterioles from WT mice vasoconstricted by 10 Ϯ 1 (0.1 nM ANG II), 19 Ϯ 2 (1 nM ANG II), and 37 Ϯ 5% of control values (10 nM ANG II) (Fig. 3) . Afferent arteriolar reductions in di- ] responses to stepwise increases in renal arterial perfusion pressure in kidneys from wild-type (WT; E, n ϭ 6) and AT1 receptor subtype-deficient (AT1AϪ/Ϫ; F, n ϭ 6) mice. Afferent arterioles from both groups responded to increases in perfusion pressure with a significant reduction in diameter. The magnitude of the afferent arteriolar vasoconstrictor responses were not significantly different between WT and AT1AϪ/Ϫ mice. *P Ͻ 0.05 vs. baseline.
from AT 1A ϩ/Ϫ were not different in those from WT or AT 1A Ϫ/Ϫ mice.
At the completion of application of ANG II, vessels were exposed to the control superfusion for a recovery period. The AT 1 receptor antagonist candesartan (1 M) was applied to the surface of the kidney for a period of 5 min. Diameters were not altered by candesartan alone in WT (n ϭ 5), AT 1A ϩ/Ϫ (n ϭ 2), or AT 1A Ϫ/Ϫ (n ϭ 11) vessels, averaging 100 Ϯ 1, 105, and 100 Ϯ 1% of control, respectively. Moreover, the AT 1 receptor antagonist completely blocked the afferent arteriolar responses to all doses of ANG II in all groups, demonstrating that the afferent arteriole vasoconstrictor responses are mediated by the AT 1 receptor subtypes.
Afferent arteriolar ANG II time control responses. This series of experiments was performed to demonstrate that afferent arterioles respond to repeated application of increasing concentrations of ANG II. Afferent arteriolar diameter in kidneys from AT 1A Ϫ/Ϫ mice (n ϭ 3) averaged 17.7 Ϯ 0.1 m at baseline. Application of 0.1, 1, and 10 nM ANG II produced graded reductions in afferent arteriolar diameter of 6 Ϯ 1, 15 Ϯ 1, and 23 Ϯ 1% of control levels, respectively (Fig. 4) . On the second application of 0.1, 1, and 10 nM ANG II, vessel diameters decreased 6 Ϯ 1, 14 Ϯ 1, and 19 Ϯ 2% of control levels, respectively. The afferent arteriolar responses to the first and second applications of ANG II did not differ significantly. Afferent arteriolar diameters were not significantly different between baseline and the two recovery periods. These data provide evidence that mouse juxtamedullary afferent arterioles do not display tachyphalaxis to ANG II at the concentrations used and respond actively to a repeat application of the peptide under these experimental conditions.
Efferent arteriolar ANG II responses. Efferent arteriole baseline diameters in kidneys from AT 1A Ϫ/Ϫ mice were significantly larger than in those from WT mice, averaging 19.6 Ϯ 0.7 and 17.0 Ϯ 0.3 m, respectively. Efferent arterioles of WT mice vasoconstricted in response to 0.1, 1, and 10 nM ANG II by 6 Ϯ 1, 11 Ϯ 1, and 21 Ϯ 5% of control (P Ͻ 0.05; Fig. 5 ). However, efferent arterioles from AT 1A Ϫ/Ϫ mice did not respond to ANG II. The AT 1 -receptor antagonist candesartan alone did not alter efferent arteriolar diameter (100% of control) of WT (n ϭ 6) or AT 1A Ϫ/Ϫ (n ϭ 6) mice. As shown in Fig. 5 , blockade of the AT 1 receptor with candesartan completely prevented the efferent arteriolar vasoconstrictor responses to ANG II in kidneys from WT mice.
DISCUSSION
The AT 1 receptor is primarily responsible for the vascular and tubular actions of the renal renin-angiotensin system. There are two unique AT 1 receptor subtypes in rodents, AT 1A and AT 1B , which cannot be distinguished using pharmacological antagonists. Accordingly, it has not been possible to discriminate between renal microvascular AT 1A and AT 1B receptor subtype function. It is known that AT 1A and AT 1B receptor mRNAs are expressed on the afferent arteriole (2, 17) . However, there is no information on the localization of AT 1B receptor mRNA or protein on the efferent arteriole. Therefore, the purpose of the present study was to determine the functional contribution of the AT 1A and AT 1B receptors to the renal microvascular responses to changes in renal perfusion pressure and the segment-specific vasoconstrictor actions of ANG II.
The requirement for AT 1A receptors for afferent arteriolar vascular control mechanisms with regard to elevations in renal arterial perfusion pressure were examined in the present study using gene-targeted mice. Although AT 1A receptor-deficient mice have been shown to lack a tubuloglomerular feedback mechanism (25) , the present study revealed that increases in renal perfusion pressure evoke indistinguishable afferent arteriolar vasoconstrictor responses in WT and AT 1A Ϫ/Ϫ mouse kidneys. Significant reductions in afferent arteriolar diameter were observed in WT, heterozygous, and homozygous AT 1A -disrupted mouse kidneys in response to stepwise increases in renal arterial pressure. The magnitude of the afferent arteriolar vasoconstriction in the mouse kidney was similar to the responses seen previously in the rat, in which single afferent arteriolar blood flow was efficiently autoregulated over the same pressure range (27) . Thus afferent arteriolar autoregulatory responsiveness in the isolated perfused mouse kidney is similar to that previously observed in the rat and does not appear to be altered by the loss of AT 1A receptor function. The maintenance of renal autoregulatory responsiveness in AT 1A Ϫ/Ϫ mice suggests a prominence of the myogenic mechanism in these animals. Alternatively, tubuloglomerular feedback responses may be active in the deep, juxtamedullary nephron population of AT 1A Ϫ/Ϫ mice and may reflect mediation by the AT 1B receptor.
The relative contributions of AT 1A and AT 1B receptors to afferent arteriolar resting tone were evaluated in the present study. Afferent arteriolar diameters were not significantly different under baseline conditions (100 mmHg renal perfusion pressure, superfusion with vehicle solution) in kidneys from WT and AT 1A Ϫ/Ϫ mice. The lack of a between-group difference in baseline diameter indicates no effect of loss of AT 1A receptors on basal afferent arteriolar tone. In addition, basal afferent arteriolar diameters were not altered after AT 1 receptor blockade by candesartan in kidneys from WT or AT 1A Ϫ/Ϫ mice. This suggests that there is little influence of ANG II on basal afferent arteriolar tone under the conditions of the isolated blood-perfused mouse kidney preparation.
The relative contributions of AT 1A and AT 1B receptors to afferent arteriolar responses to ANG II were determined in kidneys from WT, AT 1A ϩ/Ϫ and AT 1A Ϫ/Ϫ mice. The afferent arteriolar diameter responses to ANG II in WT mice were similar to those previously reported in the rats pretreated with enalprilat (3, 9) . Significant reductions in afferent arteriolar diameters were observed over the concentration range of 0.1-10 nM in kidneys from WT, AT 1A ϩ/Ϫ, and AT 1A Ϫ/Ϫ mice. We attribute the ANG II vasoconstrictor responses in afferent arterioles from AT 1A Ϫ/Ϫ mice to be mediated by the AT 1B receptor subtype. Surprisingly, the magnitude of the afferent arteriolar responses in the three groups of mice was similar at the 0.1 and 1 nM ANG II doses. This was unexpected based on previous studies, which demonstrated a negligible pressor response to bolus systemic ANG II (11) and diminished renal blood flow response to bolus intrarenal administration of ANG II (22) in kidneys from AT 1A Ϫ/Ϫ mice compared with controls. However, it has been shown that AT 1A Ϫ/Ϫ mice have significantly enhanced renal renin mRNA expression (19) and elevated plasma ANG II levels (6) . Elevated circulating ANG II may have contributed to the lack of ANG II response in kidneys from AT 1A Ϫ/Ϫ mice in the above studies. Endogenous ANG II may occupy the AT 1B receptors and limit accessability of exogenously administered ANG II. In fact, after administration of an angiotensin-converting enzyme inhibitor, both systemic pressor and renal blood flow responses to ANG II were enhanced (6, 19) . Therefore, suppression of the endogenous production of ANG II may be necessary to reveal the function of the AT 1B receptor in the absence of the AT 1A receptor. It is possible that circulating ANG II levels are low using the mouse juxtamedullary nephron technique, in which the kidney is perfused with blood obtained from a donor rat and, therefore, afferent arteriolar responses in kidneys from AT 1A Ϫ/Ϫ mice are revealed.
In contrast to the afferent arteriolar vasoconstrictor responses to low-dose ANG II, afferent arteriolar diameter responses to the high dose of ANG II, 10 nM, were significantly different in kidneys from WT and AT 1A Ϫ/Ϫ mice. Afferent arteriolar diameter responses for the AT 1A Ϫ/Ϫ mice were only 60% of the magnitude of the response for WT mice. The difference in the magnitude of the response may be due to the maximal vasoconstrictor contribution of the AT 1B receptors. The vasoconstrictor responses to ANG II were completely inhibited by the AT 1 receptor blocker candesartan. This drug blocks both the AT 1A and AT 1B receptor subtypes, similar to the properties of losartan (15) . Therefore, the vasoconstrictor effects of ANG II on the afferent arteriole are mediated by the AT 1 receptor for both WT and AT 1A Ϫ/Ϫ mice. There was no evidence of AT 2 receptor-mediated vasodilation in the presence of AT 1 receptor blockade and ANG II in the present study. We conclude that for WT mice, afferent arteriolar responses are mediated by both the AT 1A and AT 1B receptors, whereas for AT 1A Ϫ/Ϫ mice, this effect is mediated exclusively by the AT 1B receptors. In addition, in the absence of AT 1A receptors, 10 nM ANG II evokes an attenuated, candesartan-sensitive, afferent arteriolar constriction in kidneys from AT 1A Ϫ/Ϫ mice, implicating activation of AT 1B receptors. It is not known at the present time whether AT 2 and/or AT 1B receptor protein expression is altered in afferent arterioles of AT 1A Ϫ/Ϫ mice.
The relative contributions of AT 1A and AT 1B receptors to efferent arteriolar responses to ANG II were determined in kidneys from WT and AT 1A Ϫ/Ϫ mice. Efferent arterioles of WT mice responded in a dosedependent manner to ANG II, similar to juxtamedullary efferent arterioles of the rat (3, 9) . However, efferent arterioles of AT 1A Ϫ/Ϫ mice did not respond to ANG II. These data suggest that AT 1A receptors are primarily responsible for ANG II-induced efferent arteriolar vasoconstriction. The lack of ANG II responses in efferent arterioles of AT 1A Ϫ/Ϫ mice suggests that AT 1B receptors are not functionally expressed on the efferent arteriole.
In contrast to the similarities in the afferent arteriolar resting diameters of WT and AT 1A Ϫ/Ϫ mice, efferent arteriolar diameters of AT 1A Ϫ/Ϫ mice were significantly larger than for WT mice. Such increased efferent arteriolar diameter combined with an increased glomerular ultrafiltration coefficient, resulting from reduced ANG II-dependent activation of AT 1A receptors, may contribute to the maintenance of renal plasma flow and glomerular filtration rate in the normal range in hypotensive AT 1A Ϫ/Ϫ mice (6). However, there may be limitations to our ability to extrapolate our data obtained from in vitro studies to an in vivo setting. It is not likely that the larger resting efferent arteriolar diameter in kidneys from AT 1A Ϫ/Ϫ mice is a result of the direct loss of the effects of endogenous ANG II on the AT 1A receptor because resting diameter was not influenced by candesartan. At this time, we can only speculate on the potential interaction of ANG II-induced vasoconstriction and other vasodilatory mechanisms at the site of the efferent arteriole. The larger resting efferent arteriolar diameter of AT 1A Ϫ/Ϫ mice may reflect a lack of compensation by the vasoconstrictor properties of the AT 1A receptor. It has been shown that AT 1A Ϫ/Ϫ mice have increased expression and activity of neuronal nitric oxide synthase (14) . Because nitric oxide derived from neuronal nitric oxide synthase localized in the macula densa cells and efferent arterioles (1) has been shown to play an important role in renal hemodynamics, it is possible that nitric oxide has profound effects on the resting tone of the efferent arteriole lacking AT 1 receptors.
In conclusion, afferent arteriolar autoregulatory capability is not affected by the absence of AT 1A receptors. This study in AT 1A Ϫ/Ϫ mice provides functional evidence of distinct distribution patterns for AT 1 receptor subtypes within the renal microvasculature. We conclude that afferent arteriolar vasoconstrictor responses to ANG II are mediated by AT 1A and AT 1B receptors, whereas efferent arteriole vasoconstrictor responses to ANG II are mediated by only AT 1A receptors in the mouse kidney.
